Related Experiment Videos

Prevention of stroke in patients with hypertension

Björn Dahlöf1

  • 1Department of Medicine, Sahlgrenska University Hospital/Ostra, Göteborg, Sweden. bjorn.dahlof@a-plusscience.com

Insights

Conventional hypertension treatment has limitations. Angiotensin II receptor blockers (ARBs), like telmisartan, may offer superior stroke protection beyond blood pressure reduction, a benefit to be explored in the PROFESS study.

Area of Science:

  • Cardiology
  • Neurology
  • Pharmacology

Background:

  • Despite evidence for blood pressure lowering, conventional antihypertensive treatments do not fully mitigate major cardiovascular events in hypertensive patients.
  • The choice of antihypertensive agent significantly impacts long-term cardiovascular outcomes, particularly stroke risk.
  • Optimal blood pressure management requires 24-hour control, especially during early morning hours when stroke risk peaks.

Purpose of the Study:

  • To investigate the potential of angiotensin II receptor blockers (ARBs) in providing stroke protection beyond blood pressure lowering.
  • To evaluate the specific profile of the ARB telmisartan for stroke management.
  • To explore the benefits of selective angiotensin II type 1 receptor blockade and 24-hour blood pressure control for stroke prevention.

Main Methods:

  • The study will investigate the efficacy of ARBs, specifically telmisartan, in stroke prevention.
  • Focus on 24-hour blood pressure control and blood pressure-independent effects on stroke risk.
  • The Prevention Regimen for Effectively Avoiding Second Strokes (PROFESS) study will be central to the investigation.

Main Results:

  • Angiotensin II receptor blockers (ARBs) demonstrate consistent benefits in stroke protection that exceed their blood pressure-lowering effects.
  • Telmisartan exhibits a promising profile for stroke management due to its selective angiotensin II type 1 receptor blockade.
  • Consistent 24-hour blood pressure control with telmisartan offers potential for enhanced stroke prevention.

Conclusions:

  • Antihypertensive therapies with blood pressure-independent effects on stroke risk are crucial.
  • ARBs, particularly telmisartan, represent a valuable therapeutic option for improving stroke prevention in hypertensive patients.
  • Further investigation through the PROFESS study is warranted to confirm the stroke prevention potential of telmisartan.

Related Concept Videos

Hypertension IV: Drug Therapy and Lifestyle Modifications01:28

Hypertension IV: Drug Therapy and Lifestyle Modifications

Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
Atherosclerosis IV: Nursing Management01:23

Atherosclerosis IV: Nursing Management

Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...
Hypertension V: Nursing Management01:23

Hypertension V: Nursing Management

The nursing management of hypertension involves accurately assessing symptoms, making a comprehensive nursing diagnosis, collaborating with patients to set goals, and implementing targeted interventions to mitigate the condition's impact and improve patient well-being.Comprehensive AssessmentThe initial step in nursing care for hypertension involves a thorough patient assessment. It includes evaluating symptoms such as headaches, dizziness, blurred vision, and previous hypertension episodes.
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
Errors occurring during blood pressure monitoring01:25

Errors occurring during blood pressure monitoring

Blood pressure monitoring is a crucial clinical procedure in diagnosing and managing various cardiovascular conditions. Despite its significance, the accuracy of blood pressure measurements can be compromised by multiple factors, potentially leading to either falsely high or low readings. These inaccuracies are critical as they can significantly impact patient care. So, it is vital to understand these challenges deeply and adopt strategic approaches to minimize errors.
Several factors...